Pharmanutra receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pharmanutra SpA (PHNU)
Pharmanutra SpA stock price live, this page displays BIT PHNU stock exchange data. View the PHNU premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Pharmanutra SpA real time stock price chart below.
What Is the Pharmanutra SpA Stock Price Today?
The Pharmanutra SpA stock price today is 91.70.
What Is the Stock Symbol for Pharmanutra SpA?
The stock symbol for Pharmanutra SpA is "PHNU."
What Stock Exchange Does Pharmanutra SpA Trade On?
Pharmanutra SpA is listed and trades on the Milan stock exchange.
Is Pharmanutra SpA a Good Stock to Buy?
Determining whether Pharmanutra SpA, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PHNU quote. (ISIN: IT0005274094) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
What Is the Pharmanutra SpA Stock Price Today?
The Pharmanutra SpA stock price today is 91.70.
What Is the Stock Symbol for Pharmanutra SpA?
The stock symbol for Pharmanutra SpA is "PHNU."
What Stock Exchange Does Pharmanutra SpA Trade On?
Pharmanutra SpA is listed and trades on the Milan stock exchange.
Is Pharmanutra SpA a Good Stock to Buy?
Determining whether Pharmanutra SpA, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PHNU quote. (ISIN: IT0005274094) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
Milan
Currency in EUR
91.70
+3.30(+3.73%)
Closed·
Fair Value
An estimate of a Pharmanutra's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
85.30
94.45
52 wk Range
38.75
94.45
Trading near 52-week High
1/2
Fair Value
An estimate of a Pharmanutra's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
85.3094.45
52 wk Range
38.7594.45
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.35%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.35%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PHNU Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Pharmanutra's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
94.33
Upside
+2.87%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 6 consecutive years
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 94.33
(+2.87% Upside)
Earnings
Latest Release
May 11, 2026
EPS / Forecast
0.36 / --
Revenue / Forecast
33.05M / --
Compare PHNU to Peers and Sector
Metrics to compare | PHNU | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPHNUPeersSector | |
|---|---|---|---|---|
P/E Ratio | 40.3x | 17.5x | 11.6x | |
PEG Ratio | 1.39 | 0.41 | 0.03 | |
Price/Book | 11.4x | 2.4x | 1.5x | |
Price / LTM Sales | 6.1x | 1.4x | 0.9x | |
Upside (Analyst Target) | 5.2% | 10.9% | 25.8% | |
Fair Value Upside | Unlock | 15.5% | 13.5% | Unlock |
Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It offers Sucrosomial, a delivery system that optimises nutrient transport and absorption for minimising gastrointestinal side effects; and Cetylated Fatty Acids, a formulation for muscle and joint recovery in physiotherapy and sports. The company also sells instrumentation and software for body bioimpedance analysis through agents, distributors, and online sales. Pharmanutra S.p.A. was founded in 2000 and is headquartered in Pisa, Italy.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Pharmanutra (PHNU) Stock Price Today?
The Pharmanutra stock price today is 91.70 EUR.
What Stock Exchange Does Pharmanutra Trade On?
Pharmanutra is listed and trades on the Milan Stock Exchange.
What Is the Stock Symbol for Pharmanutra?
The stock symbol for Pharmanutra is "PHNU."
What Is the Pharmanutra Market Cap?
As of today, Pharmanutra market cap is 878.04M EUR.
What Is Pharmanutra's Earnings Per Share (TTM)?
The Pharmanutra EPS (TTM) is 2.20.
When Is the Next Pharmanutra Earnings Date?
Pharmanutra will release its next earnings report on May 12, 2026.
From a Technical Analysis Perspective, Is PHNU a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Pharmanutra Stock Split?
Pharmanutra has split 0 times.
How Many Employees Does Pharmanutra Have?
Pharmanutra has 128 employees.
What is the current trading status of Pharmanutra (PHNU)?
As of Jun 03, 2026, Pharmanutra (PHNU) is trading at a price of 91.70 EUR, with a previous close of 88.40 EUR. The stock has fluctuated within a day range of 85.30 EUR to 94.45 EUR, while its 52-week range spans from 38.75 EUR to 94.45 EUR.
What Is Pharmanutra (PHNU) Price Target According to Analysts?
The average 12-month price target for Pharmanutra is 94.33 EUR, with a high estimate of 98 EUR and a low estimate of 92 EUR. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +2.87% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.